State Key Laboratory of Molecular Oncology, National Cancer center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Laboratory of Molecular Oncology, Peking University Cancer Hospital & Institute, Beijing, China.
Cancer Res. 2019 Jul 1;79(13):3281-3293. doi: 10.1158/0008-5472.CAN-18-2341. Epub 2019 May 3.
Metabolic activities are often accompanied by cell-cycle progression, yet known connections between these two processes remain limited. Here, we identified the isocitrate dehydrogenase 3β (IDH3β) as a novel substrate of anaphase-promoting complex/cyclosome (APC/C)-CDH1 and an important regulator of the cell cycle. In esophageal squamous cell carcinoma (ESCC), IDH3β was posttranslationally upregulated in late G phase, and overexpression of IDH3β accelerated G-S transition, contributing to the promotion of cell proliferation and . α-Ketoglutarate (α-KG), a crucial metabolite in tricarboxylic acid (TCA) cycle, was dependent on IDH3β level and partially accounted for IDH3β-mediated cell growth. IDH3β expression increased PFKFB3 protein levels and enhanced glucose uptake, and high expression of IDH3β correlated with poor survival in patients with ESCC, suggesting a potential application of IDH3β in prognosis. Overall, our results highlight a new molecular connection between cell-cycle regulation and the TCA cycle in ESCC. SIGNIFICANCE: These findings show that IDH3β is an APC/C-CDH1 substrate and is expressed in a cell-cycle-dependent manner, highlighting novel molecular cross-talk between the TCA cycle and cell cycle in cancer cells. http://cancerres.aacrjournals.org/content/canres/79/13/3281/F1.large.jpg.
代谢活动通常伴随着细胞周期的进展,但已知这两个过程之间的联系仍然有限。在这里,我们发现异柠檬酸脱氢酶 3β(IDH3β)是后期促进复合物/周期蛋白(APC/C)-CDH1 的一种新的底物,也是细胞周期的重要调节因子。在食管鳞状细胞癌(ESCC)中,IDH3β在 G2 晚期被翻译后上调,过表达 IDH3β加速 G1-S 转换,促进细胞增殖和生长。α-酮戊二酸(α-KG)是三羧酸(TCA)循环中的一种关键代谢物,依赖于 IDH3β水平,并部分解释了 IDH3β介导的细胞生长。IDH3β表达增加了 PFKFB3 蛋白水平并增强了葡萄糖摄取,并且 IDH3β的高表达与 ESCC 患者的生存不良相关,这表明 IDH3β在预后中有潜在的应用。总的来说,我们的研究结果强调了 ESCC 中细胞周期调控与 TCA 循环之间的新分子联系。
这些发现表明 IDH3β 是 APC/C-CDH1 的底物,并且以细胞周期依赖性方式表达,突出了癌细胞中 TCA 循环和细胞周期之间的新的分子相互作用。